Likewise, treatment of scirrhous gastric cancer cells with transforming growth factor β (TGFβ), whose signaling is associated with the invasion of cancer cells, decreases ZO-2 expression and upregulates the activity of RhoA and myosin phosphorylation [104]. The gene discussed is TGFB1; the disease is gastric cancer.